Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) Sees Large Growth in Short Interest

Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Rating) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 3,060,000 shares, an increase of 323.8% from the February 28th total of 722,100 shares. Based on an average daily volume of 1,530,000 shares, the […]

Related Keywords

,Nasdaq ,Aridis Pharmaceuticals Company Profile ,Group One Trading ,Institutional Trading Of Aridis Pharmaceuticals ,Aridis Pharmaceuticals ,News Ratings For Aridis Pharmaceuticals Daily ,Ep Wealth Advisors ,Armistice Capital ,Aridis Pharmaceuticals Inc ,Vanguard Group Inc ,Aridis Pharmaceuticals Stock Down ,Get Rating ,Street Corp ,Pharmaceuticals Stock Down ,Aridis Pharmaceuticals Daily ,Nasdaq Ards ,Cards ,Medical ,Stocks ,Options ,Put ,Call ,